WATSON LABS TEVA FDA Approval ANDA 081215

ANDA 081215

WATSON LABS TEVA

FDA Drug Application

Application #081215

Application Sponsors

ANDA 081215WATSON LABS TEVA

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL3MG0ESTROPIPATEESTROPIPATE

FDA Submissions

ORIG1AP1993-09-23
LABELING; LabelingSUPPL2AP1998-10-27
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1999-11-10
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2001-01-29
MANUF (CMC); Manufacturing (CMC)SUPPL6AP2001-09-05
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2002-07-15
MANUF (CMC); Manufacturing (CMC)SUPPL8AP2002-07-15
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-11-07
LABELING; LabelingSUPPL14AP2007-02-23

Submissions Property Types

SUPPL1Null0
SUPPL3Null0
SUPPL4Null0
SUPPL6Null0
SUPPL7Null0
SUPPL8Null0
SUPPL9Null0

CDER Filings

WATSON LABS TEVA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 81215
            [companyName] => WATSON LABS TEVA
            [docInserts] => ["",""]
            [products] => [{"drugName":"ESTROPIPATE","activeIngredients":"ESTROPIPATE","strength":"3MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ESTROPIPATE","submission":"ESTROPIPATE","actionType":"3MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.